blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2965090

EP2965090 - METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.03.2019
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  23.03.2018
FormerGrant of patent is intended
Status updated on  28.09.2017
FormerExamination is in progress
Status updated on  20.02.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Randox Teoranta
Meenmore
Dungloe, Co. Donegal / IE
[2018/29]
Former [2017/43]For all designated states
Randox Teoranta
Randox Teoranta
Meenmore
Dungloe, Co. Donegal
Dungloe / IE
Former [2016/02]For all designated states
Randox Teoranta
Meenmore
Dungloe, Co. Donegal / IE
Inventor(s)01 / FITZGERALD, Peter
Randox Laboratories Ltd.
55 Diamond Road
Crumlin Antrim BT29 4QY / GB
02 / MCCONNELL, Ivan
Randox Laboratories Ltd
55 Diamond Road
Crumlin Antrim BT29 4QY / GB
03 / LAMONT, John
Randox Laboratories Ltd.
55 Diamond Road
Crumlin Antrim BT29 4QY / GB
04 / RICHARDSON, Ciaran
Randox Teoranta
Meenmore
Dungloe
Dungloe Co. Donegal / IE
 [2016/02]
Representative(s)Gill Jennings & Every LLP
The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[2018/17]
Former [2016/02]Jappy, John William Graham
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
Application number, filing date14726887.404.03.2014
[2016/02]
WO2014EP54185
Priority number, dateGB2013000393605.03.2013         Original published format: GB 201303936
[2016/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014135546
Date:12.09.2014
Language:EN
[2014/37]
Type: A1 Application with search report 
No.:EP2965090
Date:13.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.2014 takes the place of the publication of the European patent application.
[2016/02]
Type: B1 Patent specification 
No.:EP2965090
Date:25.04.2018
Language:EN
[2018/17]
Search report(s)International search report - published on:EP12.09.2014
ClassificationIPC:G01N33/68
[2016/02]
CPC:
G01N33/6896 (EP,GB,US); C07K14/4711 (GB); C12Q1/6883 (GB,US);
G16B40/00 (EP,US); G16B40/20 (EP,GB,US); C12Q2600/112 (US);
C12Q2600/158 (US); G01N2333/47 (US); G01N2333/4716 (US);
G01N2333/76 (EP,US); G01N2333/775 (US); G01N2333/81 (US);
G01N2333/8121 (US); G01N2333/912 (US); G01N2800/2821 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/02]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN FÜR DIE DIAGNOSE VON ALZHEIMERSKRANKHEIT[2017/43]
English:METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE[2016/02]
French:MÉTHODES ET COMPOSITIONS POUR LE DIAGNOSTIC DE LA MALADIE D'ALZHEIMER[2016/02]
Former [2016/02]VERFAHREN UND ZUSAMMENSETZUNGEN ZUR DIAGNOSE VON MORBUS ALZHEIMER
Entry into regional phase17.07.2015National basic fee paid 
17.07.2015Designation fee(s) paid 
17.07.2015Examination fee paid 
Examination procedure17.07.2015Examination requested  [2016/02]
22.04.2016Amendment by applicant (claims and/or description)
22.06.2016Despatch of a communication from the examining division (Time limit: M04)
21.10.2016Reply to a communication from the examining division
09.02.2017Despatch of a communication from the examining division (Time limit: M04)
15.06.2017Reply to a communication from the examining division
29.09.2017Communication of intention to grant the patent
06.02.2018Fee for grant paid
06.02.2018Fee for publishing/printing paid
06.02.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.06.2016
Opposition(s)28.01.2019No opposition filed within time limit [2019/14]
Fees paidRenewal fee
30.03.2016Renewal fee patent year 03
20.04.2017Renewal fee patent year 04
16.03.2018Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.201704   M06   Fee paid on   28.04.2017
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.03.2014
AL25.04.2018
AT25.04.2018
CY25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
MK25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
IS25.08.2018
PT27.08.2018
[2022/31]
Former [2021/32]HU04.03.2014
AL25.04.2018
AT25.04.2018
CY25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
IS25.08.2018
PT27.08.2018
Former [2021/31]AL25.04.2018
AT25.04.2018
CY25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
IS25.08.2018
PT27.08.2018
Former [2021/26]AL25.04.2018
AT25.04.2018
CY25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2020/16]AL25.04.2018
AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/51]AL25.04.2018
AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/46]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/26]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/11]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/10]AT25.04.2018
CZ25.04.2018
DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RO25.04.2018
RS25.04.2018
SE25.04.2018
SK25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/09]DK25.04.2018
EE25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RS25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/08]DK25.04.2018
FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RS25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/03]FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RS25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
PT27.08.2018
Former [2018/52]FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RS25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
GR26.07.2018
Former [2018/51]FI25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RS25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
Former [2018/50]FI25.04.2018
HR25.04.2018
LT25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
Former [2018/49]FI25.04.2018
LT25.04.2018
PL25.04.2018
SE25.04.2018
BG25.07.2018
NO25.07.2018
Former [2018/47]FI25.04.2018
LT25.04.2018
NO25.07.2018
Cited inInternational search[Y]WO2006134390  (RANDOX LAB LTD [GB], et al) [Y] 1-17 * the whole document *;
 [XY]US2007099203  (ZHANG JING [US]) [X] 14-17 * paragraphs [0007] , [0 27] , [0 46] , [0 61] - [0064] - [0 76] , [0 80] , [ 131] , [ 145]; figures 5-7; examples 1-17, 40, 42 * [Y] 1-13;
 [AP]EP2664923  (FOND ITALIANA SCLEROSI MULTIPLA FISM ONLUS [IT], et al) [AP] 1-17* the whole document *;
 [XY]  - JERKOVIC L ET AL, "Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression", JOURNAL OF PROTEOME RESEARCH, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, (20050501), vol. 4, no. 3, doi:10.1021/PR0500105, ISSN 1535-3907, pages 889 - 899, XP002371055 [X] 14-16 * page 892, column 1, lines 10-39 * * page 892, column 2, lines 43-46 * [Y] 1-13,17

DOI:   http://dx.doi.org/10.1021/pr0500105
 [Y]  - ZHANG JING ET AL, "QUANTITATIVE PROTEOMICS OF CEREBROSPINAL FLUID FROM PATIENTS WITH ALZHEIMER DISEASE", JOURNAL OF ALZHEIMER'S DISEASE, IOS PRESS, NL, (20050401), vol. 7, no. 2, ISSN 1387-2877, page 125, XP009076593 [Y] 1-17 * page 132, column 2, lines 26-37 *
 [Y]  - SONG F ET AL, "Screening plasma for biomarkers of mild cognitive impairment and Alzheimer's disease by quantitative proteomic methods", ALZHEIMER'S & DEMENTIA: THE JOURNAL OF THE ALZHEIMER'SASSOCIATION, ELSEVIER, NEW YORK, NY, US, vol. 6, no. 4, doi:10.1016/J.JALZ.2010.05.406, ISSN 1552-5260, (20100701), pages S129 - S130, (20100701), XP027438934 [Y] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jalz.2010.05.406
 [Y]  - John M Ringman ET AL, "Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations", Archives of neurology, United States, doi:10.1001/archneurol.2011.642, (20120101), pages 96 - 104, URL: http://www.ncbi.nlm.nih.gov/pubmed/22232349, XP055134102 [Y] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1001/archneurol.2011.642
 [Y]  - PETRA ZÜRBIG ET AL, "Use of proteomic methods in the analysis of human body fluids in Alzheimer research", ELECTROPHORESIS, (20121219), vol. 33, no. 24, doi:10.1002/elps.201200360, ISSN 0173-0835, pages 3617 - 3630, XP055134112 [Y] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1002/elps.201200360
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.